全球新生兒篩檢市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

預計新生兒篩檢市場將從 2025 年的 10.3425 億美元成長到 2034 年的 20.9695 億美元，2026 年至 2034 年的複合年成長率為 8.17%。

受人們對早期發現先天性和代謝性疾病重要性認知不斷提高的推動，新生兒篩檢市場正經歷顯著成長。隨著醫療機構將預防性護理和早期療育置於優先地位，對全面新生兒篩檢計畫的需求激增。串聯式質譜質譜和基因檢測等技術進步提高了篩檢多種疾病的能力，從而能夠及時診斷和治療。隨著家長和醫療專業人員認知到新生兒篩檢在改善健康結果方面發揮的關鍵作用，預計這一趨勢將進一步推動市場發展。

篩檢調查方法和技術的創新正在塑造新生兒篩檢市場的未來前景。非侵入性檢測方法和就地檢驗方案的開發提高了篩檢的可及性和便利性，使家庭能夠更快地獲得結果並進行後續護理。此外，資料管理和遠端醫療解決方案的進步正在簡化篩檢流程，並促進醫護人員與家庭之間的溝通。隨著研究的進展和可透過新生兒篩檢發現的新疾病的出現，篩檢範圍可能會擴大，涵蓋更多疾病。

此外，增加對公共衛生政策和監管支持的投入，以加強篩檢項目，將對新生兒篩檢市場產生正面影響。醫療服務提供者、政策制定者和倡導團體之間的合作對於提高公眾意識和確保全面的新生兒篩檢服務至關重要。隨著環境的變化，重點將轉向將新生兒篩檢納入更廣泛的婦幼保健策略，強調教育、後續護理和持續支持對於實現新生兒最佳健康狀態的重要性。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球新生兒篩檢市場：依產品分類

• 市場分析、洞察與預測
• 裝置
• 試劑

第5章：全球新生兒篩檢市場：依技術分類

• 市場分析、洞察與預測
• 串聯式質譜質譜法
• 脈搏血氧計
• 基於酵素的檢測
• DNA檢測
• 電泳
• 其他

第6章：全球新生兒篩檢市場：按檢測方法分類的展望

• 市場分析、洞察與預測
• 乾血斑檢查
• CCHD
• 聽力篩檢

第7章 全球新生兒篩檢市場：按地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Bio-Rad Laboratories
  • Agilent Technologies
  • Covidien Plc
  • Masimo
  • Waters Corporation
  • Natus Medical
  • Trivitron Healthcare
  • GE Lifesciences
  • PerkinElmer Inc
  • AB SCIEX

The Newborn Screening Market size is expected to reach USD 2096.95 Million in 2034 from USD 1034.25 Million (2025) growing at a CAGR of 8.17% during 2026-2034.

The newborn screening market is experiencing significant growth, driven by the increasing awareness of the importance of early detection of congenital disorders and metabolic diseases. As healthcare providers prioritize preventive care and early intervention, the demand for comprehensive newborn screening programs is surging. Advances in technology, such as tandem mass spectrometry and genetic testing, are enhancing the ability to screen for a wide range of conditions, enabling timely diagnosis and treatment. This trend is expected to propel the market forward, as parents and healthcare professionals alike recognize the critical role of newborn screening in improving health outcomes.

Innovations in screening methodologies and technologies are shaping the future of the newborn screening market. The development of non-invasive testing methods and point-of-care testing solutions is improving accessibility and convenience for families, allowing for quicker results and follow-up care. Additionally, advancements in data management and telehealth solutions are streamlining the screening process, facilitating better communication between healthcare providers and families. As research continues to uncover new conditions that can be detected through newborn screening, the market is likely to witness the expansion of screening panels to include additional disorders.

Moreover, the newborn screening market will benefit from increased investment in public health initiatives and regulatory support aimed at enhancing screening programs. Collaborative efforts between healthcare providers, policymakers, and advocacy groups will be essential in promoting awareness and ensuring access to comprehensive newborn screening services. As the landscape evolves, the focus will increasingly shift towards integrating newborn screening into broader maternal and child health strategies, emphasizing the importance of education, follow-up care, and ongoing support in achieving optimal health outcomes for newborns.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Instruments
• Reagents

By Technology

• Tandem Mass Spectrometry
• Pulse Oximetry
• Enzyme Based Assay
• DNA Assay
• Electrophoresis
• Others

By Test Type Outlook

• Dry Blood Spot Test
• CCHD
• Hearing Screen

COMPANIES PROFILED

• BioRad Laboratories, Agilent Technologies, Covidien plc, Masimo, Waters Corporation, Natus Medical, Trivitron Healthcare, GE Lifesciences, PerkinElmer Inc, AB SCIEX

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL NEWBORN SCREENING MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Reagents Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL NEWBORN SCREENING MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Technology
• 5.2. Tandem Mass Spectrometry Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Pulse Oximetry Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Enzyme Based Assay Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. DNA Assay Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Electrophoresis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL NEWBORN SCREENING MARKET: BY TEST TYPE OUTLOOK 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Test Type Outlook
• 6.2. Dry Blood Spot Test Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. CCHD Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Hearing Screen Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL NEWBORN SCREENING MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product
  • 7.2.2 By Technology
  • 7.2.3 By Test Type Outlook
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product
  • 7.3.2 By Technology
  • 7.3.3 By Test Type Outlook
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product
  • 7.4.2 By Technology
  • 7.4.3 By Test Type Outlook
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product
  • 7.5.2 By Technology
  • 7.5.3 By Test Type Outlook
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product
  • 7.6.2 By Technology
  • 7.6.3 By Test Type Outlook
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL NEWBORN SCREENING INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Bio-Rad Laboratories
  • 9.2.2 Agilent Technologies
  • 9.2.3 Covidien Plc
  • 9.2.4 Masimo
  • 9.2.5 Waters Corporation
  • 9.2.6 Natus Medical
  • 9.2.7 Trivitron Healthcare
  • 9.2.8 GE Lifesciences
  • 9.2.9 PerkinElmer Inc
  • 9.2.10 AB SCIEX